Market
Scenario
Peptic ulcer drugs are used to treat erosion of the
gastrointestinal lining due to a variety of factors. Peptic ulcer is the result
of an imbalance between aggressive and defensive fluids in the stomach. Peptic
ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer
drugs market was valued at approximately $29 billion in 2015, and is expected
to reach $36.27 billion by 2022. Thus, the market is expected to show an
average growth at a CAGR of 3.8 % from 2016 to 2022.
The major driving factors for petic ulcers drug
market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli,
changes in food, rise in cancer, tobacco and alcohol use. Constraining factors
of this market are patent expiry, comparatively good treatment regimen of
proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation
into many companies and great penetration of generics.
Key Players For
Global Peptic Ulcer Drugs Market:
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc. Helicure AB and Eumedica Pharmaceuticals
Segments:
Global peptic ulcer drugs market has been segmented on the basis of pharmacological class (proton pump inhibitors (PPIs), anti-histamines, H2 antagonists, antacids, antibiotics and others), by clinical application (gastric ulcers, duodenal ulcer, esophageal ulcer) and region.
Regional Analysis of Global Peptic Ulcer Drugs Market:
Globally North America is the largest market of global peptic ulcer drugs. Europe is the second largest market for global peptic ulcer drugs. Soon the market of peptic ulcer drugs will be dominated by developing regions particularly Asia Pacific which will be the fastest growing region.
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc. Helicure AB and Eumedica Pharmaceuticals
Segments:
Global peptic ulcer drugs market has been segmented on the basis of pharmacological class (proton pump inhibitors (PPIs), anti-histamines, H2 antagonists, antacids, antibiotics and others), by clinical application (gastric ulcers, duodenal ulcer, esophageal ulcer) and region.
Regional Analysis of Global Peptic Ulcer Drugs Market:
Globally North America is the largest market of global peptic ulcer drugs. Europe is the second largest market for global peptic ulcer drugs. Soon the market of peptic ulcer drugs will be dominated by developing regions particularly Asia Pacific which will be the fastest growing region.
Browse Complete 85 Pages Premium Research Report
Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/peptic-ulcer-drugs-market-2445
Detailed Table
of Contents:
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size
Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic
Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
Analysis
5.3 Demand & Supply:
Gap Analysis
5.4 Pricing Analysis
5.5 Investment
Opportunity Analysis
5.6 Merger And
Acquisition Landscape
...Continued
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment